Table 2. Multivariable Regression Results: Change in Health Care Service Use in March 2020a.
| Variable | Change per 10 000 persons (95% CI) | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Preventive care | Nonelective care | Elective care | Prescription drug | ||||||||||
| Colonoscopyb | Mammogramc | HbA1C test | Vaccinesd | Angioplasty | Chemotherapy | Labor and deliverye | MSK surgery | Cataract surgery | MRI | Statin | Antidiabetic | Asthma | |
| March 2020 | −28.21 (−30.51 to −25.91)f | −149.1 (−162.0 to −136.2)f | −58.97 (−63.26 to −54.69)f | −300.5 (−346.5 to −254.5)f | −0.131 (−0.268 to 0.00638) | −0.685 (−1.368 to −0.00180)g | −0.161 (−2.320 to 1.997) | −4.629 (−5.336 to −3.922)f | −1.063 (−1.432 to −0.695)f | −13.39 (−14.58 to −12.21)f | 6.450 (−8.580 to 21.48) | 2.060 (−1.337 to 5.457) | 57.14 (52.09 to 62.18)f |
| April 2020 | −64.45 (−66.75 to −62.16)f | −342.1 (−355.0 to −329.2)f | −118.1 (−122.4 to −113.9)f | −369.0 (−414.7 to −323.4)f | −0.278 (−0.415 to −0.141)g | −1.445 (−2.126 to −0.764)g | −1.219 (−3.369 to 0.931) | −10.86 (−11.57 to −10.16)f | −3.401 (−3.768 to −3.034)f | −31.39 (−32.57 to −30.20)f | −20.72 (−35.70 to −5.742)f | −3.603 (−6.989 to −0.218)g | −4.542 (−9.570 to 0.486) |
| Observations, No. | 5712 | 2856 | 19 989 | 2853 | 19 989 | 19 989 | 2856 | 19 989 | 19 989 | 19 989 | 19 989 | 19 989 | 19 989 |
| R2 | 0.723 | 0.814 | 0.914 | 0.909 | 0.472 | 0.865 | 0.558 | 0.795 | 0.807 | 0.879 | 0.841 | 0.800 | 0.727 |
| March 2019 use rate | 64.3 | 358.4 | 168.0 | 1665.6 | 0.9 | 18.9 | 34.4 | 16.0 | 3.4 | 47.8 | 248.7 | 52.7 | 174.8 |
| April 2019 use rate | 69.4 | 378.5 | 171.3 | 1632.1 | 0.8 | 19.6 | 34.9 | 16.4 | 3.7 | 50.1 | 257.1 | 54.7 | 177.3 |
| Relative change, % | |||||||||||||
| Between March 2019 and March 2020 | −43.9 | −41.6 | −35.1 | −18.0 | −15.2 | −3.6 | −0.5 | −28.9 | −31.3 | −28.0 | 2.6 | 3.9 | 32.7 |
| Between April 2019 and April 2020 | −92.9 | −90.4 | −68.9 | −22.6 | −33.0 | −7.4 | −3.5 | −66.0 | −91.1 | −62.6 | −8.1 | −6.6 | −2.6 |
Abbreviation: MSK, musculoskeletal.
a
This table shows regression-adjusted differences in use rates of preventive, nonelective, elective, and pharmaceutical care in March 2020 and April 2020, relative to the 2018 to 2020 time period. The dependent variable in each column is the monthly number of persons per 10 000 eligible persons with the respective procedure. Regression models include fixed-effect controls for year and month, state, patient sex, and age category (categorized as 0-2, 3-18, 19-26, 27-45, and 46-64 years).
b
Limited to ages 46 to 64 years.
c
Limited to women aged 46 to 64 years.
d
Limited to children aged 0 to 2 years.
e
Limited to women aged 19 to 45 years.
f
P < .05.
g
P < .01.